Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants fast track designation to SB-318 and SB-913

July 14, 2017

ViaCyte begins clinical testing of VC-02 combination product for type 1 diabetes

July 13, 2017

Erytech collaborates with Queen's University on eryminase in arginase-1 deficiency

July 13, 2017

Carmell Therapeutics closes series B financing

July 13, 2017

Amicus plans migalastat NDA for Fabry disease based on FDA communications

July 12, 2017

MAX BioPharma obtains proof-of-concept data on Oxy-200 for osteoporosis

July 12, 2017

Long-acting human GLP-1 analogue BPI-3016 demonstrates promise in preclinical studies

July 11, 2017

YH-18421 shows promise in diabetic mouse model

July 11, 2017

Mitsubishi Tanabe Pharma obtains approval in Japan for Canalia combination tablets

July 4, 2017

Swedish Orphan Biovitrum's SOBI-003 receives U.S. orphan status for MPS type III A

July 4, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...